Information Journal Paper
APA:
Copy. (2017). Erlotinib-loaded albumin nanoparticles: A novel injectable form of erlotinib and its in vivo efficacy against pancreatic adenocarcinoma ASPC-1 and PANC-1 cell lines. International Journal of Pharmacology, 531(-), 299-305. SID. https://sid.ir/paper/724506/en
Vancouver:
Copy. Erlotinib-loaded albumin nanoparticles: A novel injectable form of erlotinib and its in vivo efficacy against pancreatic adenocarcinoma ASPC-1 and PANC-1 cell lines. International Journal of Pharmacology[Internet]. 2017;531(-):299-305. Available from: https://sid.ir/paper/724506/en
IEEE:
Copy, “Erlotinib-loaded albumin nanoparticles: A novel injectable form of erlotinib and its in vivo efficacy against pancreatic adenocarcinoma ASPC-1 and PANC-1 cell lines,” International Journal of Pharmacology, vol. 531, no. -, pp. 299–305, 2017, [Online]. Available: https://sid.ir/paper/724506/en